My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 299

    1.

    Remission of chronic thrombotic thrombocytopenic purpura after treatment with cyclophosphamide and rituximab.

    Zheng X, Pallera AM, Goodnough LT, Sadler JE, Blinder MA.

    Ann Intern Med. 2003 Jan 21;138(2):105-8.PMID: 12529092 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Summaries for patients. Treatment of refractory thrombotic thrombocytopenic purpura.

    [No authors listed]

    Ann Intern Med. 2003 Jan 21;138(2):I38. No abstract available. PMID: 12529111 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases.

    Fakhouri F, Vernant JP, Veyradier A, Wolf M, Kaplanski G, Binaut R, Rieger M, Scheiflinger F, Poullin P, Deroure B, Delarue R, Lesavre P, Vanhille P, Hermine O, Remuzzi G, Grünfeld JP.

    Blood. 2005 Sep 15;106(6):1932-7. Epub 2005 Jun 2.PMID: 15933059 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature.

    Yomtovian R, Niklinski W, Silver B, Sarode R, Tsai HM.

    Br J Haematol. 2004 Mar;124(6):787-95. Review.PMID: 15009067 [PubMed - indexed for MEDLINE]Related articles

    5.

    Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP).

    Ahmad A, Aggarwal A, Sharma D, Dave HP, Kinsella V, Rick ME, Schechter GP.

    Am J Hematol. 2004 Oct;77(2):171-6.PMID: 15389904 [PubMed - indexed for MEDLINE]Related articles

    6.

    Rituximab as pre-emptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodies.

    Bresin E, Gastoldi S, Daina E, Belotti D, Pogliani E, Perseghin P, Scalzulli PR, Paolini R, Marcenò R, Remuzzi G, Galbusera M.

    Thromb Haemost. 2009 Feb;101(2):233-8.PMID: 19190804 [PubMed - indexed for MEDLINE]Related articles

    7.

    Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.

    Sadler JE.

    Blood. 2008 Jul 1;112(1):11-8. Review.PMID: 18574040 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Rituximab provided long-term remission in a patient with refractory relapsing thrombotic thrombocytopenic purpura.

    Kosugi S, Matsumoto M, Ohtani Y, Take H, Ishizashi H, Fujimura Y, Kuyama J.

    Int J Hematol. 2005 Jun;81(5):433-6. Review.PMID: 16158827 [PubMed - indexed for MEDLINE]Related articles

    9.

    Rituximab induces remission of cerebral ischemia caused by thrombotic thrombocytopenic purpura.

    Tsai HM, Shulman K.

    Eur J Haematol. 2003 Mar;70(3):183-5.PMID: 12605663 [PubMed - indexed for MEDLINE]Related articles

    10.

    Recent advances in thrombotic thrombocytopenic purpura.

    Sadler JE, Moake JL, Miyata T, George JN.

    Hematology Am Soc Hematol Educ Program. 2004:407-23. Review.PMID: 15561695 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Rituximab prevents recurrence of thrombotic thrombocytopenic purpura: a case report.

    Galbusera M, Bresin E, Noris M, Gastoldi S, Belotti D, Capoferri C, Daina E, Perseghin P, Scheiflinger F, Fakhouri F, Grünfeld JP, Pogliani E, Remuzzi G.

    Blood. 2005 Aug 1;106(3):925-8. Epub 2005 Apr 12.PMID: 15827129 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13.

    Scully M, Cohen H, Cavenagh J, Benjamin S, Starke R, Killick S, Mackie I, Machin SJ.

    Br J Haematol. 2007 Feb;136(3):451-61.PMID: 17233847 [PubMed - indexed for MEDLINE]Related articles

    13.

    Thrombotic thrombocytopenic purpura: from the bench to the bedside, but not yet to the community.

    George JN, Vesely SK.

    Ann Intern Med. 2003 Jan 21;138(2):152-3. No abstract available. PMID: 12529099 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Rituximab for acute plasma-refractory thrombotic thrombocytopenic purpura. A case report and concise review of the literature.

    Rüfer A, Brodmann D, Gregor M, Kremer Hovinga JA, Lämmle B, Wuillemin WA.

    Swiss Med Wkly. 2007 Sep 22;137(37-38):518-24. Review.PMID: 17990141 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Two cases of refractory thrombotic thrombocytopenic purpura associated with collagen vascular disease were significantly improved by rituximab treatment.

    Kameda T, Dobashi H, Kittaka K, Susaki K, Yamaoka G, Arai K, Tokuda M, Ishida T.

    Clin Rheumatol. 2007 Dec;26(12):2159-62. Epub 2007 Jun 12.PMID: 17562094 [PubMed - indexed for MEDLINE]Related articles

    16.

    [Successful treatment of idiopathic acquired refractory thrombotic thrombocytopenic purpura with an association of rituximab-vindesine. Report of one case]

    Ojeda-Uribe M, Brunot A, Issler M.

    Rev Med Chil. 2005 Nov;133(11):1349-54. Epub 2005 Dec 29. Spanish. PMID: 16446859 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity.

    Mori Y, Wada H, Gabazza EC, Minami N, Nobori T, Shiku H, Yagi H, Ishizashi H, Matsumoto M, Fujimura Y.

    Transfusion. 2002 May;42(5):572-80.PMID: 12084165 [PubMed - indexed for MEDLINE]Related articles

    18.

    Rituximab therapy for refractory thrombotic thrombocytopenic purpura.

    Gutterman LA, Kloster B, Tsai HM.

    Blood Cells Mol Dis. 2002 May-Jun;28(3):385-91.PMID: 12367582 [PubMed - indexed for MEDLINE]Related articles

    19.

    Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura.

    Furlan M, Robles R, Solenthaler M, Lämmle B.

    Blood. 1998 Apr 15;91(8):2839-46.PMID: 9531594 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    [Rituximab provided long-term remission in a patient with severe thrombotic thrombocytopenic purpura refractory to plasma exchange]

    Hong H, Aoyama Y, Yamamura R, Ohta T, Mugitani A, Yamane T, Hino M, Matsumoto M, Fujimura Y.

    Rinsho Ketsueki. 2006 Dec;47(12):1528-32. Japanese. PMID: 17233471 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity